MX2015000215A - Composiciones liquidas de racecadotrilo. - Google Patents

Composiciones liquidas de racecadotrilo.

Info

Publication number
MX2015000215A
MX2015000215A MX2015000215A MX2015000215A MX2015000215A MX 2015000215 A MX2015000215 A MX 2015000215A MX 2015000215 A MX2015000215 A MX 2015000215A MX 2015000215 A MX2015000215 A MX 2015000215A MX 2015000215 A MX2015000215 A MX 2015000215A
Authority
MX
Mexico
Prior art keywords
liquid compositions
racecadotril
racecadotril liquid
compositions
cyclodextrin
Prior art date
Application number
MX2015000215A
Other languages
English (en)
Inventor
Der-Yang Lee
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of MX2015000215A publication Critical patent/MX2015000215A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Una composición líquida que comprende racecadotrilo y ciclodextrina.
MX2015000215A 2012-06-28 2013-06-28 Composiciones liquidas de racecadotrilo. MX2015000215A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261665458P 2012-06-28 2012-06-28
US201361787496P 2013-03-15 2013-03-15
PCT/US2013/048573 WO2014005021A1 (en) 2012-06-28 2013-06-28 Racecadotril liquid compositions

Publications (1)

Publication Number Publication Date
MX2015000215A true MX2015000215A (es) 2015-04-10

Family

ID=48795918

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000215A MX2015000215A (es) 2012-06-28 2013-06-28 Composiciones liquidas de racecadotrilo.

Country Status (20)

Country Link
US (1) US9084721B2 (es)
EP (1) EP2866802B1 (es)
JP (1) JP6282644B2 (es)
KR (1) KR20150023059A (es)
CN (1) CN104411307B (es)
AU (2) AU2013282402A1 (es)
BR (1) BR112014032801A2 (es)
CA (1) CA2877724A1 (es)
CO (1) CO7160079A2 (es)
ES (1) ES2600628T3 (es)
HK (1) HK1208177A1 (es)
IN (1) IN2014DN11007A (es)
MX (1) MX2015000215A (es)
NZ (1) NZ702930A (es)
PH (1) PH12014502860B1 (es)
PT (1) PT2866802T (es)
RU (1) RU2643325C2 (es)
SG (1) SG11201408565VA (es)
WO (1) WO2014005021A1 (es)
ZA (1) ZA201500620B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS57221B2 (sr) 2008-10-22 2020-08-31 Array Biopharma Inc Jedinjenja supstituisanog pirazolo[1,5-]pirimidina kao inhibitori trk kinaze
SG11201408565VA (en) 2012-06-28 2015-02-27 Mcneil Ppc Inc Racecadotril liquid compositions
AU2013282413B2 (en) 2012-06-28 2018-04-19 Mcneil-Ppc, Inc. Racecadotril lipid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
CN105125477A (zh) * 2015-08-19 2015-12-09 黑龙江佰彤儿童药物研究有限公司 一种含消旋卡多曲的药物制剂及制备方法
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
KR102400423B1 (ko) 2016-04-04 2022-05-19 록쏘 온콜로지, 인코포레이티드 (s)-n-(5-((r)-2-(2,5-디플루오로페닐)-피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-하이드록시피롤리딘-1-카복사미드의 액체 제형
LT3800189T (lt) 2016-05-18 2023-10-10 Loxo Oncology, Inc. (s)-n-(5-((r)-2-(2,5-difluorfenil)pirolidin-1-il)pirazolo[1,5-a]pirimidin-3- il)-3-hidroksipirolidin-1-karboksamido gavimas
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
WO2018163195A1 (en) * 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
FR2673105B1 (fr) * 1991-02-26 1995-01-13 Bioprojet Soc Civ Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
CN1635884A (zh) * 2000-06-23 2005-07-06 生物计划公司 包含外消旋卡朵曲的干粉制剂
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
WO2005117911A2 (en) * 2004-05-06 2005-12-15 Cydex, Inc. Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
JP2009013140A (ja) * 2007-07-09 2009-01-22 Japan Science & Technology Agency シクロデキストリン包接体水懸濁液及びその製造方法
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
SG11201408565VA (en) 2012-06-28 2015-02-27 Mcneil Ppc Inc Racecadotril liquid compositions
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions

Also Published As

Publication number Publication date
EP2866802A1 (en) 2015-05-06
AU2018202482A1 (en) 2018-04-26
WO2014005021A1 (en) 2014-01-03
KR20150023059A (ko) 2015-03-04
JP6282644B2 (ja) 2018-02-21
US9084721B2 (en) 2015-07-21
ES2600628T3 (es) 2017-02-10
EP2866802B1 (en) 2016-07-27
CN104411307A (zh) 2015-03-11
HK1208177A1 (en) 2016-02-26
NZ702930A (en) 2017-05-26
CO7160079A2 (es) 2015-01-15
PT2866802T (pt) 2016-09-05
IN2014DN11007A (es) 2015-09-25
PH12014502860A1 (en) 2015-02-23
RU2015102575A (ru) 2016-08-20
JP2015522030A (ja) 2015-08-03
SG11201408565VA (en) 2015-02-27
US20140005261A1 (en) 2014-01-02
RU2643325C2 (ru) 2018-01-31
CA2877724A1 (en) 2014-01-03
CN104411307B (zh) 2017-04-26
AU2013282402A1 (en) 2015-01-22
BR112014032801A2 (pt) 2017-06-27
ZA201500620B (en) 2017-09-27
PH12014502860B1 (en) 2015-02-23

Similar Documents

Publication Publication Date Title
PH12014502860A1 (en) Racecadotril liquid compositions
HK1212597A1 (zh) 用於調節 表達的組合物
EP2850190A4 (en) COMPOSITIONS AND METHOD FOR MODULATING MECP2 EXPRESSION
EP3055414A4 (en) Compositions for modulating c9orf72 expression
AP2014008100A0 (en) Compositions and methods for modulating hemoglobingene family expression
EP2850187A4 (en) COMPOSITIONS AND METHODS FOR PTEN EXPRESSION MODULATION
EP3068833A4 (en) Polymeric compositions comprising polyisoprene
HK1205189A1 (en) Methods and compositions for modulating factor vii expression vii
EP3016991A4 (en) Liquid molding compositions
AU2014207408A8 (en) Pharmaceutical compositions comprising nitroxyl donors
PH12015502014A1 (en) Racecadotril lipid compositions
PH12014502858A1 (en) Racecadotril lipid compositions
PL2828301T3 (pl) Zmodyfikowane kompozycje polimerowe
EP2992334A4 (en) Novel phosphatidylalkanols and compositions thereof
HK1208375A1 (en) Improved complexes and compositions containing curcumin
AU352808S (en) Dispenser for curable compositions
EP2881431A4 (en) VISCOUS COMPOSITION
MX369290B (es) Inhibidores de fbx03.
PH12015502061A1 (en) Racecadotril liquid compositions
EP2970540A4 (en) ANAEROBICALLY CURABLE COMPOSITIONS
GB201222908D0 (en) Curable liquid compositions
MX2015008588A (es) Composiciones y metodos para la transfeccion de polinucleótidos.
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
EP2905011A4 (en) PERFUME COMPOSITION
HK1151718A1 (en) Flupentixol compositions